I looked at the ClinicalTrials.gov Results Database several years ago, and decided it was an improvement over just having the published paper because of its strucyure, but was far short of having the raw data [see eyes wide shut open I…, eyes wide shut open II…, eyes wide shut open III…, and eyes wide shut […]
In why data transparency? I…, I was looking at the recently published RCT of Symbiax®, an Eli Lily COMBO drug with Prozac® and Zyprexa® in various doses [Olanzapine/Fluoxetine Combination in Children and Adolescents With Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Trial]. I was disappointed that the JAACAP was publishing such an obviously COI-laden experimercial […]
Study Finds Olanzapine-Fluoxetine Combo Superior to Placebo for Bipolar Disorder in Children PSYCHIATRICNEWS alert [The Voice of the American Psychiatric Association and the Psychiatric Community] December 30, 2014 A combination of the antipsychotic olanzapine and the antidepressant fluoxetine proved superior to placebo for acute treatment of bipolar I depression in patients aged 10-17 in a […]